Neuronal oxidative damage and dendritic degeneration following activation of CD14-dependent innate immune response in vivo

AUTOR(ES)

Milatovic, Dejan

FONTE

BioMed Central

RESUMO

The cause-and-effect relationship between innate immune activation and neurodegeneration has been difficult to prove in complex animal models and patients. Here we review findings from a model of direct innate immune activation via CD14 stimulation using intracerebroventricular injection of lipopolysaccharide. These data show that CD14-dependent innate immune activation in cerebrum leads to the closely linked outcomes of neuronal membrane oxidative damage and dendritic degeneration. Both forms of neuronal damage could be blocked by ibuprofen and alpha-tocopherol, but not naproxen or gamma-tocopherol, at pharmacologically relevant concentrations. This model provides a convenient method to determine effective agents and their appropriate dose ranges for protecting neurons from CD14-activated innate immunity-mediated damage, and can guide drug development for diseases, such as Alzheimer disease, that are thought to derive in part from CD14-activated innate immune response.

Documentos Relacionados

• Altered innate immune response of plasmacytoid dendritic cells in multiple sclerosis
• Saturable CD14-dependent binding of fluorescein-labeled lipopolysaccharide to human monocytes.
• Coexistence of CD14-dependent and independent pathways for stimulation of human monocytes by gram-positive bacteria.
• Lipopolysaccharide-Binding Protein- and CD14-Dependent Activation of Mitogen-Activated Protein Kinase p38 by Lipopolysaccharide in Human Neutrophils Is Associated with Priming of Respiratory Burst
• Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway.